Health of mothers of children with a life-limiting condition: a protocol for comparative cohort study using the Clinical Practice Research Datalink.

developmental neurology & neurodisability life-limiting maternal health

Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
13 07 2020
Historique:
entrez: 16 7 2020
pubmed: 16 7 2020
medline: 15 5 2021
Statut: epublish

Résumé

There are now nearly 50 000 children with a life-limiting or life-threatening condition in the UK. These include conditions where there is no reasonable hope of cure and from which they will die, as well as conditions for which curative treatment may be feasible but can fail, for example, cancer or heart failure. Having a child with a life-limiting condition involves being a coordinator and provider of healthcare in addition to the responsibilities and pressures of parenting a child who is expected to die young. This adversely affects the health and well-being of these mothers and affects their ability to care for their child, but the extent of the impact is poorly understood.This study aims to quantify the incidence and nature of mental and physical morbidity in mothers of children with a life-limiting condition, their healthcare use and to assess whether there is a relationship between the health of the mother and the child's condition. A comparative cohort study using data from the Clinical Practice Research Datalink and linked hospital data will include three groups of children and their mothers (those with a life-limiting condition, those with a chronic condition and those with no long-term health condition total=20 000 mother-child dyads). Incidence rates and incidence rate ratios will be used to quantify and compare the outcomes between groups with multivariable regression modelling used to assess the relationship between the child's disease trajectory and mother's health. This study protocol has approval from the Independent Scientific Advisory Committee for the UK Medicines and Healthcare products Regulatory Agency Database Research. The results of this study will be reported according to the STROBE and RECORD guidelines. There will also be a lay summary for parents which will be available to download from the Martin House Research Centre website (www.york.ac.uk/mhrc).

Identifiants

pubmed: 32665342
pii: bmjopen-2019-034024
doi: 10.1136/bmjopen-2019-034024
pmc: PMC7359378
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e034024

Subventions

Organisme : Department of Health
ID : CDF-2018-11-ST2-002
Pays : United Kingdom

Informations de copyright

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Disabil Rehabil. 2009;31(8):607-18
pubmed: 19360498
J Intellect Disabil Res. 2011 Mar;55(3):263-80
pubmed: 21199042
Int J Epidemiol. 2015 Jun;44(3):827-36
pubmed: 26050254
BMJ. 2009 Jun 29;338:b2393
pubmed: 19564179
Br J Psychiatry. 2016 May;208(5):453-61
pubmed: 26795424
BMC Med. 2003 Dec 23;1:3
pubmed: 14690540
BMJ Open. 2014 Aug 01;4(8):e005331
pubmed: 25085264
BMC Palliat Care. 2013 Dec 11;12(1):43
pubmed: 24330676
Disabil Health J. 2017 Oct;10(4):565-570
pubmed: 28347641
Pediatrics. 2012 Apr;129(4):e923-9
pubmed: 22412035
Pediatrics. 2004 Aug;114(2):e182-91
pubmed: 15286255

Auteurs

Lorna Katharine Fraser (LK)

Health Sciences, University of York, York, North Yorkshire, UK lorna.fraser@york.ac.uk.

Fliss E M Murtagh (FEM)

Wolfson Palliative Care Research Centre, Hull York Medical School, University of Hull, Hull, UK.

Trevor Sheldon (T)

Health Sciences, University of York, York, North Yorkshire, UK.

Simon Gilbody (S)

Health Sciences, University of York, York, North Yorkshire, UK.

Catherine Hewitt (C)

Health Sciences, University of York, York, North Yorkshire, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH